Abstract Objective 25-Hydroxyvitamin D3 [25(OH)D3] is the main product of vitamin D and can reflect the absolute concentration of active vitamin D in the body. This study examined serum 25(OH)D3 levels in children with juvenile idiopathic arthritis (JIA) in order to explore the association of vitamin D concentrations with the pathogenesis and disease activity of JIA. Methods Serum samples were collected from 53 children confirmed as having JIA between January 2013 and March 2014, as well as 106 healthy children (control group) who underwent physical examination in the same period. Serum concentrations of 25(OH)D3 were measured using ELISA and compared between the cases and healthy controls. The association of serum 25(OH)D3 levels with JIA subtypes, ACR Pediatric 30 Score, peripheral blood C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were analyzed in children with JIA. Results Compared with the control group, the JIA group had significantly reduced serum 25(OH)D3 levels (median: 42.6 nmol/L vs 49.9 nmol/L; P<0.01). The percentage of subjects with severe deficiency of vitamin D in the JIA group was significantly higher than that in the control group (17.0% vs 6.6%; P<0.05). Serum 25(OH)D3 showed no significant correlations with JIA subtypes, ACR Pediatric 30 Score, CRP, and ESR in children with JIA. Conclusions Vitamin D concentrations are significantly decreased in children with JIA. Decreased vitamin D concentrations may be associated with the pathogenesis of JIA. However, vitamin D concentrations may have no correlations with JIA subtypes, disease severity, and disease activity.
Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001[J]. J Rheumatol, 2004, 31(2): 390-392.
Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations[J]. Ann Rheum Dis, 2007, 66(6): 1137-1142.
[5]
Misra M, Pacaud D, Petryk A, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations[J]. Pediatrics, 2008, 122(2): 398-417.
[6]
Nisar MK, Masood F, Cookson P, et al. What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence[J]. Clin Rheumatol, 2013, 32(6): 729-734.
[7]
Szymanska KJ, Biernacka ZM, Stanczyk J. Vitamin D level in children with juvenile idiopathic arthritis and its correlation with clinical picture of the disease[J]. Reumatologia, 2013, 51(4): 271-276.
[8]
Pel a jo CF, Lopez-Beni t e z JM, Ken t DM, et a l . 25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?[J]. Rheumatol Int, 2012, 32(12): 3923-3929.
[9]
Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status[J]. Osteoporos Int, 2005, 16(7): 713- 716.
[10]
Holick MF. Resurrection of vitamin D deficiency and rickets[J]. J Clin Invest, 2006, 116(8): 2062-2072.
[11]
Holick MF. Vitamin D deficiency[J]. N Engl, 2007, 357(3): 266- 281.
Dankers W, van Hamburg JP, Mus AM, et al. 1,25(OH)2D3 inhibits Th17 cytokine production and ROR gamma t expression through GATA3/IL4-dependent and -independent mechanisms[J]. Arthr Rheumat, 2013, 65(10): S302-S302.
[15]
Ranganathan P, Khalatbari S, Yalavarthi S, et al. Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis[J]. J Rheumatol, 2013, 40(9): 1529-1534.
[16]
Reed A, Haugen M, Pachman LM. Abnormalities in serum osteocalcin values in children with chronic rheumatic disease[J]. J Pediatr, 1990, 116(4): 574-580.
[17]
Drozdenko G, Heine G, Worm M. Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL-17- producing T cells[J]. Exp Dermatol, 2014, 23(2): 107-112.
[18]
Munekata RV, Terreri MT, Peracchi OA, et al. Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis[J]. Braz J Med Biol Res, 2013, 46(1): 98-102.
[19]
Bouaddi I, Rostom S, El Badri D, et al. Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis[J]. BMC Musculoskel Dis, 2014, 15: 115.
[20]
Gibson DS, Newell K, Evans AN, et al. Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis[J]. J Proteomics, 2012, 75(17): 5479-5492.
